Diagnostic Role of Serum CA 19-9 for Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis

This publication has 13 references indexed in Scilit:

• Clinical Applications of Serum Tumor Markers
  Annals of Internal Medicine, 1991
• Natural history and prognostic variables in primary sclerosing cholangitis
  Gastroenterology, 1991
• Cholangiocarcinoma Complicating Primary Sclerosing Cholangitis
  Annals of Surgery, 1991
• Sensitive serum markers for detecting pancreatic cancer
  Cancer, 1988
• Prospective Evaluation of the Diagnostic Efficacy of CA 19–9 Assay as a Marker for Gastrointestinal Cancers
  Digestion, 1986
• Hepatobiliary carcinoma associated with primary sclerosing cholangitis and chronic ulcerative colitis
  Human Pathology, 1985
• Carbohydrate Antigenic Determinant (CA 19–9) and Other Tumor Markers in Gastrointestinal Malignancies
  Digestion, 1985
• Primary Sclerosing Cholangitis
  New England Journal of Medicine, 1984
• Initial clinical evaluation of an immunoradiometric assay for CA 19‐9 using the nci serum bank
  International Journal of Cancer, 1984
• Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases.
  Journal of Clinical Pathology, 1984